Literature DB >> 20184582

Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection.

L Nosotti, F Francesconi, S Izzi, E Berardesca, A Morrone, C Bonifati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20184582     DOI： 10.1111/j.1365-2133.2010.09714.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  Management of psoriasis patients with hepatitis B or hepatitis C virus infection.

Authors:  Claudio Bonifati; Viviana Lora; Dario Graceffa; Lorenzo Nosotti
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 2.  Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.

Authors:  Xuefen Li; Xia Liu; Li Tian; Yu Chen
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

3.  Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab.

Authors:  Sze-Wen Ting; Yi-Cheng Chen; Yu-Huei Huang
Journal:  Clin Drug Investig       Date:  2018-09       Impact factor: 2.859

Review 4.  Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management.

Authors:  Maria Vittoria Cannizzaro; Chiara Franceschini; Maria Esposito; Luca Bianchi; Alessandro Giunta
Journal:  Psoriasis (Auckl)       Date:  2017-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.